Contact Information: CONTACT INFORMATON: Amanda Zuniga 919-433-0210
Pharmaceutical Companies Release Negative Trial Results on a More Regular Basis
| Source: Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - October 31, 2007) - A new study released by Cutting
Edge Information, available at http://www.PharmaPublicationStrategy.com,
examines medical publication efforts of pharmaceutical companies across a
wide range of therapeutic areas. The study finds that, in response to
legislation and pressure from the general public, pharmaceutical companies
are now more regularly releasing both positive and negative results of
their trials.
Rather than toss out adverse trial outcomes, pharmaceutical companies make
them public both through traditional academic journals and through other
mediums, such as www.clinicaltrials.gov, an online registry for clinical
trials. Although regulatory scrutiny plays a role in this publication
practice, concerns from the general public -- payers, physicians, and
ultimately the patients themselves -- especially encourage openness.
"Companies find it worthwhile to release complete trial results, whether
positive or negative," says Amanda Zuniga, a senior research analyst at
Cutting Edge Information. "Doing so shows the public that a company is
acting in an honest, transparent manner." In addition, most companies
adhere to one or more sets of publication guidelines that encourage
frankness and full disclosure of clinical performance.
Despite the strides that companies have taken toward transparency in their
publications, journal outlets are often opposed to publishing negative
outcomes. In response, some companies take advantage of Internet
databases, and others target a different set of journals when publishing
unexpected trial outcomes. According to the study, still other companies
tackle this hurdle by publishing in a niche category of journals that
caters to adverse trial results and clinical trial replications. Whatever
method they use, pharmaceutical companies are sure to gain the trust of
their customers through comprehensive trial disclosure.
"Pharmaceutical Medical Publications: Market Preparation & Strategic
Support" (http://www.PharmaPublicationStrategy.com), was designed to
explore pharmaceutical companies' medical publications structures,
strategies and processes. The study delves into the resource support and
funding that various medical publication departments and teams benefit
from. In addition, through this report, readers will be exposed to some of
the industry's best medical publication practices and should be better
positioned to streamline their own strategies and processes by benchmarking
their efforts against those of top-leading companies.
Download a free summary of "Pharmaceutical Medical Publications" or
purchase the report at
http://www.cuttingedgeinfo.com/pharmapublicationstrategy/PH104_Download.asp#body.